WET AGE-RELATED MACULAR DEGENERATION
Clinical trials for WET AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could free patients from monthly eye injections
Disease control Not yet recruitingThis early-stage study is testing a new one-time gene therapy called EXG202 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can safely deliver a vision-protecting protein long-term, potentially replacing the…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Jiayin Biotech Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can grandma use this app? study tests home Eye-Tracker for seniors
Knowledge-focused Not yet recruitingThis study is testing how easy a new web-based eye-tracking system is for older adults with age-related macular degeneration (AMD) to use at home. Researchers want to see if the system's simple design helps people with vision problems monitor their eye health independently. The s…
Matched conditions: WET AGE-RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC